Persistent AFib Referral Guide for GPs
This information is intended for healthcare professionals.
Persistent atrial fibrillation is generally defined as AF lasting more than seven days, including episodes terminated by cardioversion after that duration. It sits between paroxysmal AF and long-standing persistent AF, and prompts review of symptom burden, ventricular rate, stroke risk, atrial size, structural heart disease and comorbidity profile.
Persistent AFib usually involves long-term anticoagulation decisions, rate or rhythm control review, comorbidity management and specialist referral in general practice where symptoms, recurrence or structural disease complicate management.
When does persistent AF warrant further specialist review, including cardiology, electrophysiology or cardiothoracic surgical assessment?
In Melbourne, consider referral to Mr Adrian Pick where persistent or recurrent AF requires thoracic surgical opinion, especially when structural cardiac disease or combined operative planning is relevant.
Confirming Persistent AFib
Diagnosis relies on ECG confirmation of AF, with duration established through history, prior ECGs, Holter monitoring, event monitoring or device data where available. Assessment includes:
- Symptom burden and functional limitation
- Ventricular rate at rest and with activity
- AF duration and prior cardioversion history
- Echocardiographic findings, including atrial size, valve disease and ventricular function
- Thyroid function, renal function and electrolyte status
- Contributing conditions such as hypertension, obesity, diabetes, alcohol use and obstructive sleep apnoea
Urgent specialist assessment is required where AF is associated with haemodynamic instability, syncope, rest angina, ischaemic ECG change, decompensated heart failure or rapid ventricular response with marked symptoms.
Stroke Risk and Anticoagulation
Stroke prevention remains at the core to AF care. Australian guidance supports CHA2DS2-VA assessment, with anticoagulation decisions based on thromboembolic risk and clinical context.
DOACs are commonly used for non-valvular AF, with renal function, age, body weight, drug interactions and bleeding history considered before prescribing and during follow-up. Warfarin remains relevant for patients with mechanical heart valves or moderate to severe mitral stenosis.
Bleeding risk tools can help identify modifiable bleeding factors, but elevated bleeding risk does not automatically exclude anticoagulation. It prompts closer review of blood pressure, renal function, alcohol intake, interacting medicines and antiplatelet use.
Rate and Rhythm Control
Management usually involves a decision between rate control, rhythm control or a staged combination.
| Strategy | When it is generally used | Common treatment options |
| Rate control | Symptoms are minimal, ventricular rate is controlled or sinus rhythm is unlikely to be sustained. | Beta blockers or rate-limiting calcium channel blockers, depending on ventricular function, blood pressure and comorbidities. |
| Rhythm control | Symptoms persist despite rate control, AF contributes to reduced ventricular function, or AF recurs after cardioversion. | Antiarrhythmic medication, electrical cardioversion, catheter ablation or surgical rhythm-control procedures in selected patients. |
Recent international guidance places comorbidity management, stroke prevention, symptom control and repeated reassessment at the centre of AF care, aligning with GP-led management of blood pressure, weight, diabetes, sleep apnoea, alcohol intake and cardiovascular risk factors.
How This Fits into General Practice
General practice remains a key setting for ongoing AF care, usually including the monitoring of symptoms, pulse and blood pressure, reviewing anticoagulation, checking renal function, identifying medication issues and managing comorbid conditions that contribute to AF progression.
Persistent AF also affects broader cardiovascular risk. Regular review of hypertension, diabetes, weight, alcohol intake, sleep apnoea and coronary risk factors can influence symptom burden and treatment suitability.
Where referral is made, useful information includes ECGs, Holter or event monitor results, echocardiogram findings, cardioversion history, ablation history, current medications, renal function, anticoagulation history and symptom impact.
When to Consider Specialist Review
Specialist review may be useful where persistent AF involves:
- Ongoing symptoms despite rate or rhythm-control therapy
- Recurrent AF after electrical cardioversion
- Recurrent AF after catheter ablation
- AF associated with mitral valve disease or other structural cardiac disease
- AF with heart failure or suspected tachycardia-mediated cardiomyopathy
- Medication intolerance or limited pharmacological options
- Complex anticoagulation decisions
- Review of rhythm-control strategy
- Consideration of surgical or combined operative options
Cardiology and electrophysiology input may guide medication, cardioversion and catheter-based options. Cardiothoracic review becomes relevant where AF coexists with structural disease, prior rhythm-control treatment has not settled symptoms, or surgical rhythm-control options are being considered.
Referral to Mr Adrian Pick
Mr Adrian Pick provides cardiothoracic review for patients with persistent or recurrent AF where surgical rhythm-control planning is required. This includes AF associated with structural cardiac disease, recurrence after catheter ablation, or rhythm management being planned alongside valve or other cardiac surgery.
Assessment is guided by AF duration, previous rhythm-control treatment, imaging, valve status, ventricular function, comorbidities and anticoagulation history.
Cardiothoracic review helps define surgical suitability and guide treatment planning in AF management.
References:
Australian Institute of Health and Welfare. (2024). Heart, stroke and vascular disease: Australian facts. Australian Government. https://www.aihw.gov.au/reports/heart-stroke-vascular-diseases/hsvd-facts/contents/about
Australian Journal of General Practice. (2020). Atrial fibrillation. https://www1.racgp.org.au/ajgp/2019/october/atrial-fibrillation
European Society of Cardiology. (2024). 2024 ESC Guidelines for the management of atrial fibrillation. https://www.escardio.org/guidelines/clinical-practice-guidelines/all-esc-practice-guidelines/atrial-fibrillation/
Heart Foundation. (2024). Australian clinical guidelines for the diagnosis and management of atrial fibrillation. https://www.heartfoundation.org.au/for-professionals/atrial-fibrillation-for-professionals
This article is intended for healthcare professionals and provides general educational information to support referral decision-making in cardiothoracic care. It is not a substitute for independent clinical judgement or specialist medical advice. Mr Adrian Pick MBBS, FRACS | Gen Surg, FRACS | Cardiothoracic (MED0001117736) is a Cardiothoracic Specialist based in Melbourne, Australia.